Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01313910 · ClinicalTrials.gov registry record · Early Phase 1
CCRC: A Project of the Treatment of HIV Enteropathy With ImmunoLin® Supplements
A Early Phase 1 study, sponsored by University of California, Davis.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 8
- Enrollment target
NCT01313910: Completed Early Phase 1 study, sponsored by University of California, Davis.
NCT01313910 is a Early Phase 1 study that has completed, run by University of California, Davis. The registered enrollment target is 8 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01313910, a Early Phase 1 study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of the study is to see if ImmunoLin® will reduce the frequency of bowel movements and gastrointestinal (GI) symptoms in HIV volunteers with persistent GI symptoms. The study will also examine the effect of ImmunoLin® on the bacteria in the gut and the immune system in gut tissue as well as in the blood.
Primary Outcome
self-reported bowel movement in diary
Interventions
- DIETARY_SUPPLEMENT Immunolin®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-08 |
| Phase | Early Phase 1 |
What the finished NCT01313910 record still lists
NCT01313910 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which Immunolin® is the first listed.
NCT01313910 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01313910 about?
NCT01313910 is a clinical study titled "CCRC: A Project of the Treatment of HIV Enteropathy With ImmunoLin® Supplements". The purpose of the study is to see if ImmunoLin® will reduce the frequency of bowel movements and gastrointestinal (GI) symptoms in HIV volunteers with persistent GI symptoms. The study will also examine the effect of ImmunoLin® on the bacteria in the gut and the immune system in gut tissue as well ...
What is the current status of trial NCT01313910?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 8 participants. The study started on 2011-03. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01313910?
The interventions under investigation include: Immunolin® (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01313910?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01313910's enrollment target sits among peer trials
8 1783rd of 2000 higher than 176 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia